Ontology highlight
ABSTRACT: Background
There are an increasing number of studies using simulation models to conduct cost-effectiveness analyses for type 2 diabetes mellitus.Objective
To evaluate the relationship between improvements in glycosylated haemoglobin (HbA1c) and simulated health outcomes in type 2 diabetes cost-effectiveness studies.Methods
A systematic review was conducted on MEDLINE and EMBASE to collect cost-effectiveness studies using type 2 diabetes simulation models that reported modelled health outcomes of blood glucose-related interventions in terms of quality-adjusted life-years (QALYs) or life expectancy (LE). The data extracted included information used to characterise the study cohort, the intervention's treatment effects on risk factors and model outcomes. Lin
SUBMITTER: Hua X
PROVIDER: S-EPMC5306373 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature